Scientific Excellence. Regulatory Confidence.
Integrated clinical research, bioequivalence, advanced bioanalysis, stability programs, and specialized testing delivered to international regulatory standards across GCC, MENA, and Europe.
About Zidiligence
Established in 2014 by Dr. Mosaad Morsi in Egypt, Zidiligence was founded with a clear mission to deliver reliable clinical and bioanalytical research services built on GCP, GLP, and international regulatory compliance. Over the years, operations have expanded into a fully integrated pharmaceutical research group supporting sponsors across GCC, MENA, and European markets.
Our Capabilities
Our range of services supports pharmaceutical companies through critical stages of research, testing, and validation.
Bioequivalence Studies
Controlled clinical studies in healthy volunteers designed to demonstrate equivalence between test and reference products, supported by integrated clinical, laboratory, and pharmacokinetic operations for regulatory submission.
Phase I to IV Clinical Trials
Licensed clinical facilities and medical teams conducting ethically governed trials to evaluate safety, bioavailability, and therapeutic performance in volunteers and patients.
Stability Studies
Monitored stability chambers and environmental storage programs to evaluate product integrity under long term, accelerated, and controlled conditions in accordance with international guidelines.
In Vitro Dissolution and Comparative Studies
Dissolution and comparative testing performed according to USP, FDA, and BCS guidelines to support product evaluation and biowaiver applications.
Food and Supplement Testing
Laboratory testing services to assess the safety, quality, and regulatory compliance of food products and dietary supplements.
Why Zidiligence
Scientific Excellence, Exceptional Quality & Innovative solutions
Quality is assured at every step, from Protocol Development to Regulatory Submission.
Responsive project management with clear, transparent communication throughout your study.
Nimble and agile, able to adapt quickly and make adjustments whenever your study requires.
On-time results from experts in PK, Data Management, and Medical Writing.
Experience that Matters
Eight years of advancing studies that contribute to better outcomes in global human health.
600+
studies completed
100+
sponsors served
200+
validated analytical methods
80+
scientific and operational professionals
Research and Scientific Contribution
Continuous scientific publications and research contributions in pharmacokinetics, bioequivalence, and advanced bioanalysis across antiviral, hormonal, and complex drug compounds demonstrate a strong commitment to scientific advancement alongside operational excellence.
Our Clients
We are proud to support pharmaceutical organizations across the region and internationally with dependable research and testing services.
Scientific Articles & Updates
Stay informed with insights, updates, and scientific contributions from our research and clinical teams.
Date Published: May 2021
Rapid LC-MS/MS Method for Favipiravir Bioanalysis in Human Plasma
This study presents a novel, sensitive LC-MS/MS method for quantifying favipiravir, a potential antiviral for COVID-19, in human plasma. Using simple...
Date Published: August 2019
UPLC-MS/MS Method for Flibanserin Bioanalysis in Human Plasma
This study developed a rapid and highly sensitive UPLC-MS/MS method for measuring flibanserin in human plasma using flibanserin d4 as an internal standa...